Global Electronic Drug Delivery Systems Market Overview:
Electronic drug delivery systems are complex but small electronics medical devices, used to infuse drugs, growth hormones, and medicines of desired quantity in patients. It offers precise and desired functionality, wireless connectivity, and user-friendly intuitive interfaces. It allows patients to administer therapy and make patients independent of caregivers, drug regimens, and medical professionals. Technological advancements in drug delivery devices have led to the development of electronic drug delivery devices, owing to improved efficacy, cost and time effectiveness, autonomous patient-administered therapy, and minimum side effects. Some of the players profiled in the study are Merck Group (Germany), United Therapeutics Corporation (United States), Bayer AG (Germany), Insulet Corporation (United States), Tandem Diabetes Care (United States), Medtronic PLC (Ireland), F. Hoffmann-La Roche (Switzerland), Novo Nordisk (Denmark), Amgen (United States) and AstraZeneca (United Kingdom).
On the basis of geography, the market of Electronic Drug Delivery Systems has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Distribution Channel, the sub-segment i.e. Offline (Hospital Pharmacies, Retail Pharmacies) will boost the Electronic Drug Delivery Systems market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by End-User, the sub-segment i.e. Hospitals will boost the Electronic Drug Delivery Systems market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Connectivity, the sub-segment i.e. Bluetooth will boost the Electronic Drug Delivery Systems market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Component, the sub-segment i.e. Sensors will boost the Electronic Drug Delivery Systems market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
Market Growth Drivers
- Growing Prevalence of Target Diseases
- Favorable Reimbursement Scenario in Major Markets
- Advancements in Technologies and Designs
Restraints
- Preference for Alternative Drug Delivery Modes and the Possibility of Errors
- Disadvantages Associated With Electronic Device Operation and Functionality
Opportunities
- Increasing Demand for Biologics and Mabs
- Growth Opportunities in Emerging Markets
Challenges
- Unfavorable Reimbursement Structure in Developing Countries
Key Market Developments:
In November 2018, United Therapeutics has signed a licensing agreement with Arena Pharmaceuticals to commercialize Arena’s hypertensive drug - Ralinepag.
In January 2020 Medtronic plc has launched Efficio–a cloud-based management software, which can be used with SynchroMed II intrathecal drug delivery system. This software launched helped the physicians to manage their targeted drug delivery pump in order to treat chronic pain.
Target Audience:
Electronic Drug Delivery Systems Manufacturers, Component Suppliers, Traders/Distributors/Exporters/Importers, Hospitals & Clinics, End-Use Industries and Others
Major Objectives Focused through this Study
To define, describe, and forecast the Global Electronic Drug Delivery Systems market on the basis of product [Wearable Infusion Pumps, Autoinjectors, Injection Pens, Inhalers and Others] , application [Cardiovascular Disease, Diabetes, Multiple Sclerosis, Respiratory Disorders and Others], key regions and end user
To provide in-depth information regarding major influencing factors affecting the growth of the market (trends, drivers, restraints, opportunities, and industry-centric and regional challenges)
To strategically analyse the micro-markets and important business segments with respect to individual growth drivers , market trends and potential, and historical contributions to the total market
Identifying the opportunities in the market for key stakeholders and detailing the competitive landscape for market leaders
To provide market size for various segments of the Electronic Drug Delivery Systems market with respect to major geographies, namely, South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico)
To strategically profile the key players and analyzing their market shares and core competencies in the Electronic Drug Delivery Systems industry
To track key developments such as product launches, expansions, agreements, partnerships, mergers & acquisitions, and R&D activities that are key factors in shaping the market
Available Customization:
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**. Additionally, the Players which are also part of the research are Companion Medical (United States), FindAir SP. Z O. O. (Poland), ViCentra B.V. (Netherland), Canè SPA (Italy) and Debiotech S.A. (Switzerland).
** Confirmation on availability of data would be informed prior purchase
While framing the research framework, major and emerging players operating in the Electronic Drug Delivery Systems market in various regions have been profiled, and their offerings, geographic footprints, and distribution/sales channels have been analysed through in-depth discussions. The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, analyst team keeps preparing set of questionnaires and after getting appointee list; the target audience are then tapped and segregated with various mediums and channels that are feasible for making connection that includes email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey etc.